Shares of biopharmaceutical company Axsome Therapeutics ( AXSM -6.29%) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol ...

Follow all the latest UEFA Youth League 2024/2025 news from the official UEFA.com site. Includes latest news stories, videos, ...

EDP Renewables North America (EDPR NA) launched the 100-MW Riverstart III Solar Park in Randolph County, Indiana, today.

Cerevance’s attempt to unlock the first-line Parkinson's disease market has hit a snag, with solengepras performing no better ...

Upadacitinib sustains its efficacy in non-radiographic axial spondyloarthritis through 2 years without presenting any new ...

While Bitcoin’s year-to-date return reflects an 11.4% loss, and the asset is down nearly 25% from its all-time high, ...

The first official Squid kill was scored by the frigate HMS Loch Killin (Pennant. No. K391) (poetically apropos moniker, eh?) ...

Researchers from the Institute of Solid State Physics, the Hefei Institutes of Physical Science of the Chinese Academy of ...

A phase 3 trial plans to further assess neoadjuvant darovasertib for the potential treatment of patients with primary uveal ...

A mom who piled on the pounds after gorging on nightly dinner dates in the “newlywed phase” has lost almost 200lbs so she can ...

It is possible three games are going to be indicative of the hitters now having a tool that will need to be banned. Or it is ...

Eli Lilly's lepodisiran met Phase 2 trial goals, significantly lowering Lp(a) levels. A Phase 3 study is enrolling to assess ...